Genetically Engineered Autolytic Bacterial Vaccines for Reducing Pathogen Colonization and Enhancing Immune Response

Scientists engineered a Salmonella vaccine by adding genes that cause the bacteria to self-destruct inside host cells, boosting immune responses and reducing Salmonella in chickens, while also promoting beneficial gut bacteria for better protection against infection.

Background

Salmonella enterica, particularly serovars like Typhimurium and Enteritidis, represents a significant global public health challenge as a leading cause of foodborne illness. These resilient bacterial pathogens frequently colonize the gastrointestinal tracts of poultry, such as chickens, establishing a primary reservoir for human infection. Consequently, developing effective strategies to control Salmonella in food animal populations is paramount for enhancing food safety and significantly reducing the widespread incidence of human salmonellosis.

Current approaches to mitigate Salmonella in poultry, particularly through vaccination, face substantial limitations. Existing attenuated Salmonella vaccines often provide only partial or short-lived protection, struggling to effectively prevent bacterial colonization and subsequent shedding in infected animals. This inherent constraint means that current vaccination methods are not fully adequate in breaking the transmission cycle from poultry to humans, highlighting a critical need for innovative and more potent vaccine technologies to address this persistent public health threat.

Technology

This technology involves a genetically modified, non-pathogenic Salmonella Typhimurium strain engineered to self-destruct within host cells. It incorporates bacteriophage P22 lysis genes (holin and lysozyme) into its chromosome, driven by an endogenous promoter. While growing normally outside cells, this modification triggers autolysis, or programmed cell death, once the bacteria infect host cells. This process releases bacterial components, which in turn strongly stimulate the host’s immune system, leading to enhanced expression of pro-inflammatory cytokines and immune receptors. Furthermore, it significantly reduces bacterial colonization in the host and beneficially alters the gut microbial composition.

This approach offers significant advantages over current vaccination strategies by providing a more effective reduction of Salmonella colonization and shedding. The key differentiator is its autolytic property, which ensures the bacteria do not persist indefinitely within the host, enhancing safety while simultaneously delivering a potent immune stimulus through the release of antigens upon cell lysis. This controlled self-destruction mechanism, coupled with the beneficial modulation of the gut microbiota, creates an unfavorable environment for pathogenic Salmonella, leading to a stronger and more sustained immune response than conventional attenuated vaccines.

Benefits

  • Effectively reduces Salmonella Typhimurium colonization and fecal shedding in poultry
  • Stimulates robust innate and adaptive immune responses via enhanced cytokine and Toll-like receptor expression
  • Autolytic bacterial design ensures controlled bacterial lysis inside host cells, improving antigen release and safety
  • Maintains normal bacterial growth and adhesion characteristics for effective vaccine delivery
  • Beneficially modulates gut microbiota by increasing beneficial bacteria and decreasing pathogenic Proteobacteria
  • Potential for oral administration, facilitating easy and scalable vaccination of poultry flocks
  • Offers improved efficacy compared to existing Salmonella vaccines with potential for multivalent vaccine development

Applications

  • Poultry Salmonella vaccination
  • Gut microbiota modulation in livestock
  • Foodborne pathogen control in poultry
  • Development of autolytic bacterial vaccines

Additional info

This genetically engineered *Salmonella Typhimurium* strain incorporates bacteriophage P22 lysis genes (holin, lysozyme) into its chromosome. Expressed intracellularly, these genes induce autolysis, releasing antigens. This modification reduces bacterial colonization, enhances immune responses, and modulates gut microbiota, serving as a vaccine for poultry.